Application of β-Galactosidase Enzyme Complementation Technology as a High Throughput Screening Format for Antagonists of the Epidermal Growth Factor Receptor
Open Access
- 1 December 2001
- journal article
- research article
- Published by Elsevier in SLAS Discovery
- Vol. 6 (6) , 401-411
- https://doi.org/10.1177/108705710100600606
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cell-Based Versus Isolated Target Screening: How Lucky Do You Feel?SLAS Discovery, 2001
- Development of a Homogeneous MAP Kinase Reporter Gene Screen for the Identification of Agonists and Antagonists at the CXCR1 Chemokine ReceptorSLAS Discovery, 2001
- Characterization of NFκB Activation by Detection of Green Fluorescent Protein-tagged IκB Degradation in Living CellsPublished by Elsevier ,1999
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Orphan G‐protein‐coupled receptors: the next generation of drug targets?British Journal of Pharmacology, 1998
- Structure−Function Studies of Ligand-Induced Epidermal Growth Factor Receptor DimerizationBiochemistry, 1998
- Fluorescent-protein biosensors: New tools for drug discoveryTrends in Biotechnology, 1998
- A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor ActivationJournal of Biological Chemistry, 1997
- Epidermal Growth Factor-related Peptides Activate Distinct Subsets of ErbB Receptors and Differ in Their Biological ActivitiesJournal of Biological Chemistry, 1996
- Transcriptional Regulation by Extracellular signals: Mechanisms and SpecificityCell, 1995